Researchers used medical error data, hospital data and U.S. payor claims to calculate the number of adverse drug events associated with injectable medications and the resulting costs.
Click here to read the full story on adverse drug events in Becker’s Hospital Review.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.